Study With Heparin Sodium in Intravenous Administration

Inclusion Criteria: * Eligible healthy participants should sign the Informed Consent Form, * be between 18 and 60 years of age, * be male, * present a BMI ≥ 18.5 and ≤ 29.9 kg / m2, * be characterized as a voluntary (Normal physical examination) * no history of current or recent diseases. Exclusion Criteria: * hemoglobin \<12 g / dL; * Platelets \<100 x 109 / L; * Regular or last 30 days use of anticoagulant medications; * Current or past use of anti-inflammatory or anti-platelet medications; * History of gastrointestinal bleeding; * History of venous thrombosis, pulmonary embolism, coagulopathies or any coagulation disorder; * Any other chronic illness or regular use of drugs that at the discretion of the investigator contraindicates participation in the study, * serious comorbidity (at the discretion of the researcher) of any nature that could compromise participation in the study or put the participant at risk considered to be unacceptable, * Laboratory that at the discretion of the investigator contraindicates the participation of the participant in the study; * Hypersensitivity or contraindication to the components of the medications studied, participation in another clinical study in less than 1 year (unless justified by the investigator) * donation of blood (\> 500 mL) in the preceding 3 months.